Head-to-head · WeighScore
BeyondMD vs Peter MD
The verdict
Peter MD takes it — 78.1/100 to 66.8/100.
Peter MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A Miami-founded telehealth that starts tirzepatide at $149 the first month (then $249/mo, billed quarterly) and runs semaglutide, TRT, sermorelin and NAD+ on the same account.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | BeyondMD | Peter MD |
|---|---|---|
| WeighScore | 66.8/100 | 78.1/100 |
| Grade | C | C+ |
| Scorecard rank | #173 | #33 |
| Semaglutide | $139/mo (starting dose, compounded) | $139-149/mo (compounded w/ B12) |
| Tirzepatide | $209/mo (starting dose, compounded) | $149 first month, then $249/mo (quarterly) |
| Coverage | Coverage not published | Most states — exclusions vary by treatment |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #173 · C
Strengths
- Aggressively low monthly pricing
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Where it loses points
- Limited public information on program details
Graded #33 · C+
Strengths
- Broad multi-category catalog on one account — TRT, GLP-1, ED, non-GLP-1 weight loss, men's hair loss and NAD+
- Physician-prescribed, nationwide telehealth operating since 2021
- Genuinely cheap TRT entry — $79/mo testosterone cypionate on a 12-month plan
- Low tirzepatide first-month rate ($149) at a real 60mg dose
Where it loses points
- Tirzepatide steps up from $149 the first month to $249/mo, billed quarterly
- Semaglutide's own pricing is hard to compare at a glance — $149/mo for first-time patients vs $139/mo for returning ones, with very different total costs ($447 vs $834) over similar supply windows
- The affiliate program discloses a wider list of state exclusions (varying by treatment, touching AL, AR, CA, ID, IA, KY, LA, MA, MI, NC, SC and TX) than any single customer-facing pricing page states
- TRT and tirzepatide both require locking into quarterly or 12-month billing to get the advertised rate
- No named medical director or lab/monitoring detail published; customer reviews are mixed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 509 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.